Clin Mol Hepatol.
2024 Apr;30(2):281-283. 10.3350/cmh.2024.0214.
Correspondence on Letter regarding “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”
- Affiliations
-
- 1Department of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan
- 2Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
- 3Department of Advanced Metabolic Hepatology, Osaka University, Graduate School of Medicine, Osaka, Japan
- KMID: 2554438
- DOI: http://doi.org/10.3350/cmh.2024.0214
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Reply to correspondence on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”
- Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study
- Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
- Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
- LETter To the EditoR Standards (LETTERS): Considerations for Authors, Reviewers, and Editors
